Vega Francisco, Padula Anthony, Valbuena Jose R, Stancu Mirela, Jones Dan, Medeiros L Jeffrey
Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, Tex 77030, USA.
Arch Pathol Lab Med. 2006 Oct;130(10):1497-502. doi: 10.5858/2006-130-1497-LITPAC.
Pleural involvement by lymphoma is relatively common. However, there are very few clinicopathologic studies reported in the literature of lymphomas involving the pleura.
To characterize the clinicopathologic features of lymphomas involving the pleura.
We reviewed the clinicopathologic features of 34 patients with lymphoma involving the pleura proven by biopsy and classified these neoplasms using the World Health Organization classification.
There were 22 men and 12 women, with an average age of 62 years (range, 22-82 years). Nine (26.5%) patients had pleural involvement as the only site of disease, 22 (64.7%) had other sites of involvement, and 3 (8.8%) had inadequate staging data. Eighteen (56.2%) of 32 patients with adequate clinical data had a history of lymphoma (including 3 patients with pleural involvement as the only disease site). In 29 (85.3%) cases, a specific diagnosis according to the World Health Organization classification could be made: 17 (58.6%) diffuse large B-cell lymphoma, 5 (17.2%) follicular lymphoma (including a case with areas of diffuse large B-cell lymphoma), 2 (6.9%) small lymphocytic lymphomas/chronic lymphocytic leukemia, 2 (6.9%) precursor T-cell lymphoblastic lymphoma/leukemia, 1 (3.4%) mantle cell lymphoma, 1 (3.4%) posttransplant lymphoproliferative disorder, and 1 (3.4%) classical Hodgkin lymphoma. The other 5 cases were B-cell lymphomas that could not be further classified. Cytologic examination of pleural fluid was performed in 15 cases and was positive for lymphoma in 8 (53.3%) cases.
Most patients with lymphoma involving the pleura have simultaneous evidence of systemic involvement. The most frequent type is diffuse large B-cell lymphoma, followed by follicular lymphoma. Cytologic examination can have negative results in patients with pleural involvement by lymphoma.
淋巴瘤累及胸膜相对常见。然而,文献中报道的关于累及胸膜的淋巴瘤的临床病理研究非常少。
描述累及胸膜的淋巴瘤的临床病理特征。
我们回顾了34例经活检证实累及胸膜的淋巴瘤患者的临床病理特征,并根据世界卫生组织分类对这些肿瘤进行分类。
男性22例,女性12例,平均年龄62岁(范围22 - 82岁)。9例(26.5%)患者胸膜受累为唯一疾病部位,22例(64.7%)有其他受累部位,3例(8.8%)分期数据不完整。32例有充分临床数据的患者中,18例(56.2%)有淋巴瘤病史(包括3例胸膜受累为唯一疾病部位的患者)。29例(85.3%)病例可根据世界卫生组织分类做出明确诊断:17例(58.6%)弥漫性大B细胞淋巴瘤,5例(17.2%)滤泡性淋巴瘤(包括1例有弥漫性大B细胞淋巴瘤区域的病例),2例(6.9%)小淋巴细胞淋巴瘤/慢性淋巴细胞白血病,2例(6.9%)前体T细胞淋巴母细胞淋巴瘤/白血病,1例(3.4%)套细胞淋巴瘤,1例(3.4%)移植后淋巴增殖性疾病,1例(3.4%)经典型霍奇金淋巴瘤。另外5例为无法进一步分类的B细胞淋巴瘤。15例患者进行了胸水细胞学检查,8例(53.3%)淋巴瘤呈阳性。
大多数累及胸膜的淋巴瘤患者同时有全身受累的证据。最常见的类型是弥漫性大B细胞淋巴瘤,其次是滤泡性淋巴瘤。淋巴瘤累及胸膜的患者细胞学检查可能为阴性结果。